1. bookTom 49 (2015): Zeszyt 2 (June 2015)
Informacje o czasopiśmie
License
Format
Czasopismo
eISSN
1581-3207
Pierwsze wydanie
30 Apr 2007
Częstotliwość wydawania
4 razy w roku
Języki
Angielski
Otwarty dostęp

Thyroid lesions incidentally detected by 18F-FDG PET-CT ― a two centre retrospective study

Data publikacji: 25 Mar 2015
Tom & Zeszyt: Tom 49 (2015) - Zeszyt 2 (June 2015)
Zakres stron: 121 - 127
Otrzymano: 29 Jun 2014
Przyjęty: 22 Sep 2014
Informacje o czasopiśmie
License
Format
Czasopismo
eISSN
1581-3207
Pierwsze wydanie
30 Apr 2007
Częstotliwość wydawania
4 razy w roku
Języki
Angielski

1. Jin J, McHenry CR. Thyroid incidentaloma. Best Pract Res Clin Endocrinol Meta 2012; 26: 83-96.10.1016/j.beem.2011.06.00422305454Search in Google Scholar

2. Bertagna F, Treglia G, Piccardo A, Giubbini R. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J Clin Endocrinol Metab 2012; 97: 3866-75.10.1210/jc.2012-239022904176Search in Google Scholar

3. Treglia G, Muoio B, Giovanella L, Salvatori M. The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview. Eur Arch Otorhinolaryngol 2012; 270: 1783-7.10.1007/s00405-012-2205-223053387Search in Google Scholar

4. Cistaro A, Quartuccio N, Mojtahedi A, Fania P, Filosso PL, Campenni A, et al. Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing (18)F-FDG PET/CT SUV quantification. Radiol Oncol 2013; 47: 219-23.10.2478/raon-2013-0023379487624133385Search in Google Scholar

5. Maza S, Buchert R, Brenner W, Munz DL, Thiel E, Korfel A, et al. Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma. Radiol Oncol 2013; 47: 103-10.10.2478/raon-2013-0016369108423801905Search in Google Scholar

6. Moon E-H, Lim ST, Han Y-H, Jeong YJ, Kang Y-H, Jeong H-J, et al. The usefulness of F-18 FDG PET/CT-mammography for preoperative staging of breast cancer: comparison with conventional PET/CT and MR-mammography.Radiold Oncol; 2013; 47: 390-7.10.2478/raon-2013-0031381428524294185Search in Google Scholar

7. Karantanis D, Bogsrud TV, Wiseman GA, Mullan BP, Subramaniam RM, Nathan MA, et al. Clinical Significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med 2007; 48: 896-901.10.2967/jnumed.106.03902417504869Search in Google Scholar

8. Kurata S, Ishibashi M, Hiromatsu Y, Kaida H, Miyake I, Uchida M, et al. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDGPET: prevalence of thyroid cancer and Hashimoto’s thyroiditis. Ann Nucl Med 2007; 21: 325-30.10.1007/s12149-007-0030-217705011Search in Google Scholar

9. Yasuda S, Shohtsu A, Ide M, Takagi S, Takahashi W, Suzuki Y, et al. Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology 1998; 207: 775-8.10.1148/radiology.207.3.96099039609903Search in Google Scholar

10. Lowe VJ, Mullan BP, Hay ID, McIver B, Kasperbauer JL. 18F-FDG PET of patients with Hürthle cell carcinoma. J Nucl Med 2003; 44: 1402-6.Search in Google Scholar

11. Chen Y-K, Ding H-J, Chen K-T, Chen Y-L, Liao AC, Shen Y-Y, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 2005; 25: 1421-6.Search in Google Scholar

12. Chu QD, Connor MS, Lilien DL, Johnson LW, Turnage RH, Li BDL. Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center. Am Surg 2006; 72: 272-5.10.1177/000313480607200315Search in Google Scholar

13. Choi JY, Lee KS, Kim H-J, Shim YM, Kwon OJ, Park K, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med 2006; 47: 609-15.Search in Google Scholar

14. Katz SC, Shaha A. PET-associated incidental neoplasms of the thyroid. J Am Coll Surg 2008: 207: 259-64.10.1016/j.jamcollsurg.2008.02.01318656056Search in Google Scholar

15. Barnabei A, Ferretti E, Baldelli R, Procaccini A, Spriano G, Appetecchia M. Hurthle cell tumours of the thyroid. Personal experience and review of the literature. Acta Otorhinolaryngol Ital 2009; 29: 305-11.Search in Google Scholar

16. Pagano L, Samà MT, Morani F, Prodam F, Rudoni M, Boldorini R, et al. Thyroid incidentaloma identified by ¹8F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol 2011; 75: 528-34.10.1111/j.1365-2265.2011.04107.x21575027Search in Google Scholar

17. Bonabi S, Schmidt F, Broglie MA, Haile SR, Stoeckli SJ. Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact. Eur Arch Otorhinolaryngol 2012; 269: 2555-60.10.1007/s00405-012-1941-722298251Search in Google Scholar

18. Ohba K, Sasaki S, Oki Y, Nishizawa S, Matsushita A, Yoshino A, et al. Factors associated with fluorine-18-fluorodeoxyglucose uptake in benign thyroid nodules. Endocr J 2012; 60: 985-90.10.1507/endocrj.EJ13-0155Search in Google Scholar

19. Bertagna F, Treglia G, Piccardo A, Giovannini E, Bosio G, Biasiotto G, et al. F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value. Endocrine 2013; 43: 678-85.10.1007/s12020-012-9837-223179777Search in Google Scholar

20. Huang SC. Anatomy of SUV. Standardized uptake value. Nucl Med Biol 2000; 27: 643-6.Search in Google Scholar

21. Kang BJ, O JH, Baik JH, Jung SL, Park YH, Chung SK. Incidental thyroid uptake on F-18 FDG PET/CT: correlation with ultrasonography and pathology. Ann Nucl Med 2009; 23: 729-37.10.1007/s12149-009-0299-419768518Search in Google Scholar

22. Kim BH, Na MA, Kim IJ, Kim S-J, Kim Y-K. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation Ann Nucl Med 2010; 24: 721-8.Search in Google Scholar

23. Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 2005; 115: 1074-8.10.1097/01.MLG.0000163098.01398.7915933524Search in Google Scholar

24. Are C, Hsu JF, Ghossein RA, Schöder H, Shah JP, Shaha AR. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDGPET)- detected incidental thyroid carcinomas. Ann Surg Oncol 2007; 14: 3210-5.10.1245/s10434-007-9531-417713821Search in Google Scholar

25. Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Collins DA, et al. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl Med Comun 2007; 28: 373-81.10.1097/MNM.0b013e3280964eae17414887Search in Google Scholar

26. Kwak JY, Kim E-K, Yun M, Cho A, Kim MJ, Son EJ, et al. Thyroid incidentalomas identified by 18F-FDG PET: sonographic correlation. Am J Roentgenol 2008; 91: 598-603.10.2214/AJR.07.344318647938Search in Google Scholar

27. Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nucl Med Commun 2009; 30: 240-4.10.1097/MNM.0b013e328324b43119262287Search in Google Scholar

28. Pampaloni MH, Win AZ. Prevalence and Characteristics of Incidentalomas Discovered by Whole Body FDG PETCT. Int J Mol Imaging 2012; 18: 1-6.Search in Google Scholar

29. Nguyen NC, Kaushik A, Wolverson MK, Osman MM. Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study. Acta Oncol 2011; 50: 670-7.10.3109/0284186X.2010.55093321247262Search in Google Scholar

30. de Langen AJ, Vincent A, Velasquez LM, van Tinteren H, Boellaard R, Shankar LK, et al. Repeatability of 18F-FDG uptake measurements in tumors: a metaanalysis. J Nucl Med 2012; 53: 701-8.10.2967/jnumed.111.09529922496583Search in Google Scholar

31. Makris NE, Huisman MC, Kinahan PE, Lammertsma AA, Boellaard R. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures. Eur J Nucl Med Mol Imaging 2013; 40: 1507-15.10.1007/s00259-013-2465-0670448223754762Search in Google Scholar

32. King D, Stack B, Spring P, Walker R, Bodenner D. Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. Otolaryngol Head Neck Surg 2007; 137: 400-4.10.1016/j.otohns.2007.02.03717765765Search in Google Scholar

33. Bertagna F, Giubbini R. F18-FDG-PET/CT thyroid incidentalomas and their benign or malignant nature: a critical and debated issue. Ann Nucl Med 2010; 25: 151-2.10.1007/s12149-010-0443-121104345Search in Google Scholar

34. Ohba K, Nishizawa S, Matsushita A, Inubushi M, Nagayama K, Iwaki H, et al. High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodeoxyglucose [corrected] positron emission tomography in relatively young healthy subjects: results of 3-year follow-up. Endocr J 2010; 57: 395-401.10.1507/endocrj.K10E-00820160400Search in Google Scholar

35. Nishimori H. Incidental thyroid “PETomas”: clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake. Can J Surg 2011; 54: 83-8.10.1503/cjs.023209311670421251421Search in Google Scholar

36. Treglia G, Annunziata S, Muoio B, Salvatori M, Ceriani L, Giovanella L. The role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: An overview. Int J Endocrinol 2013; 2013: 1-6.10.1155/2013/856189363865623653645Search in Google Scholar

37. Zaletel K, Gaberscek S, Pirnat E. Ten-year follow-up of thyroid epidemiology in Slovenia after increase in salt iodization. Croat Med J 2011; 52: 615-21.10.3325/cmj.2011.52.615319597021990079Search in Google Scholar

38. Cooper DS, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-214.10.1089/thy.2009.011019860577Search in Google Scholar

39. Boerner AR, Voth E, Theissen P, Wienhard K, Wagner R, Schicha H. Glucose metabolism of the thyroid in Graves’ disease measured by F-18-fluorodeoxyglucose positron emission tomography. Thyroid 1998; 8: 765-72.10.1089/thy.1998.8.7659777746Search in Google Scholar

40. Liu Y. Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography. Ann Nucl Med 2009; 23: 17-23.10.1007/s12149-008-0198-019205834Search in Google Scholar

41. Ho T-Y, Liou M-J, Lin K-J, Yen T-C. Prevalence and significance of thyroid uptake detected by 18F-FDG PET. Endocrine 2011; 40: 297-302. 10.1007/s12020-011-9470-521505891Search in Google Scholar

Polecane artykuły z Trend MD

Zaplanuj zdalną konferencję ze Sciendo